15/01/2007
London, UK – 15 January, 2007: ReGen Therapeutics Plc (the ‘Company’) announces that it has today received notification from Mr Tigran Kalaydjian that he has acquired 1,000,000 ordinary shares of the Company at 1.05p per share. Mr Kalaydjian now holds and is beneficially interested in 22,000,000 ordinary shares representing 3.17% of the current issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Tel. 020 7960 6007
Greycoat Communications